.svg)
For years, injections were the go-to for GLP-1 weight-loss support. But with the FDA approval of the Wegovy® pill, that’s starting to change. If you’ve ever thought, “Why can’t I just take a pill for this?” while looking for fridge space to store your injection pens, that’s a reality more and more people are already living.
Before you start using any treatment for weight management—whether it’s injections or pills—it’s important to know all your facts first. This article breaks down everything you need to know about the Wegovy pill vs. injection, from cost to clinical results to real-life experience.
What is Wegovy?
Wegovy is a prescription medication containing semaglutide. It’s manufactured by Novo Nordisk and is FDA-approved for weight management in adults with obesity (BMI 30 or higher) or overweight (BMI 27 or higher) with at least one weight-related condition (hypertension, prediabetes, etc.).
As of January 2026, Wegovy is available in two forms:
- Injection: The original weekly self-administered injection, available in doses from 0.25 mg up to 2.4 mg, with a higher-dose option (Wegovy HD® 7.2 mg) also available.
- Pill: The Wegovy pill was the first GLP-1 pill FDA-approved for weight management, launching in January 2026. It is taken once daily, with doses starting at 25 mg.
Both formats work the same way at the molecular level. They mimic GLP-1, a naturally occurring gut hormone that signals fullness, reduces appetite, slows digestion and helps regulate blood sugar. While outcomes are similar, the way they are delivered is different, which can affect everything from your daily routine to how much you’ll pay for medication.
.jpg)
Is the Wegovy pill cheaper than injections?
Cost will vary depending on your insurance coverage, but if you’re paying with cash, the Wegovy pill is cheaper than injections. The prices below are what you would pay if you pay directly through NovoCare Pharmacy. (This is much cheaper than the list price at retail pharmacies, which is around $1,300 per month.)
How much the Wegovy pill costs without insurance
- Starter dose: $149/month
- Maintenance dose: $299/month
How much Wegovy injections cost without insurance
- Starter dose: $199/month
- Maintenance dose: $349/month
Wegovy cost with insurance coverage
Those who have insurance coverage for weight management may qualify for Novo Nordisk’s Wegovy Savings Offer, which can reduce your monthly cost to as little as $25 per month for either the pill or the injection. (Note: this offer is not currently available to Medicare or Medicaid beneficiaries.)
Check with your provider, pharmacy, and/or insurance company to verify how much you’ll pay for Wegovy, as the out-of-pocket amount can vary widely.
The bottom line on cost
For uninsured patients or those paying out-of-pocket, the Wegovy pill is the more affordable option, starting $50/month lower than the injection. For insured patients using the savings card, both formats can cost as little as $25/month.
To find the lowest price for your situation:
- Compare pharmacy prices: NovoCare Pharmacy has better self-pay pricing than retail chains. You can also get competitive prices through legitimate telehealth platforms like Shed.
- Check your insurance: Call your insurer to ask about Wegovy pill vs. injection coverage, including whether it’s covered for weight management (some carriers only cover Wegovy for diabetes management).
- Apply for the Novo Nordisk Savings Card at novocare.com if you have qualifying health insurance.
- Consider telehealth platforms: If you don’t have insurance coverage, telehealth platforms can be a good way to get the medication you need at an affordable price. Shed members can get the Wegovy pill or injection through Shed’s Membership program.
How does insurance coverage work for the Wegovy pill or injection?
Insurance coverage for Wegovy in either form can be a complicated landscape to navigate. Here’s what you should know about 2026 coverage.
Commercial health insurance
Most major insurers cover both Wegovy formulations, but coverage criteria, prior authorization requirements, and copays can differ quite a bit between the pill and injection. Some plans may prefer one form over the other, or you may need to try one option before the other is covered.
There’s really no good way to get the answers you need without calling your insurer directly. Be ready to ask these questions:
- Is the Wegovy pill covered in my plan?
- Are Wegovy injections covered in my plan?
- What is my estimated copay for each?
- Is prior authorization required?
Medicare
Medicare coverage for weight-loss medications remains limited. Traditional Medicare Part D does not cover medications prescribed solely for weight management. However, because Wegovy is also approved to reduce the risk of major cardiovascular events (heart attack, stroke, death), Medicare coverage may be available if your provider prescribes it under that indication. However, coverage is not guaranteed and depends on your specific plan and diagnosis.
Medicaid
As of January 2026, only 13 state Medicaid programs covered GLP-1 medications for weight loss, and budget pressures have led some states to scale back. Coverage varies widely.
Key takeaway
Neither form of Wegovy has universally better insurance coverage. Your individual plan determines which is covered and at what cost; don’t assume the pill is covered just because the injection is. Always verify what your cost responsibility is.
Does the Wegovy pill work as well as the shots?
A pill that helps you lose weight may seem too good to be true, so it makes sense that this is a question on a lot of people’s minds. While more study has been done on injections, both forms of Wegovy have produced meaningful weight loss in clinical trials.
What the clinical trials show
The Wegovy pill was approved based on results from the OASIS 4 phase 3 trials, a 64-week randomized, double-blind, placebo-controlled study of 307 adults with obesity or overweight.* Study findings include:
- With full treatment adherence: Oral semaglutide 25 mg produced 16.6% mean weight loss at 64 weeks, vs. 2.7% with placebo
- Regardless of adherence: Average weight loss was 13.6% vs. 2.4% for placebo
- About 1 in 3 participants who adhered to treatment lost 20% or more of their body weight
The injectable Wegovy 2.4 mg, by comparison, has shown approximately 14.9% average weight loss in trials, slightly higher than the pill’s average 13.6% result, though the difference narrows when comparing fully adherent populations.
One of the reasons the Wegovy pill has a higher dose is because oral semaglutide relies on an absorption enhancer to help it survive digestion and has lower systemic bioavailability compared to injectable forms. But when taken as prescribed, both options support weight-loss efforts. The injection may edge out the pill slightly in average outcomes, but individual results vary and adherence matters more than the format.
Does the Wegovy pill have the same side effects as injections?
Both the pill and injection share similar side effects, which makes sense given they contain the same active ingredient. The most common side effects include:
- Nausea (especially after dose increases)
- Diarrhea
- Constipation
- Vomiting
- Stomach discomfort or bloating
- Fatigue
In the OASIS 4 trial, serious adverse events actually occurred less frequently with oral semaglutide than with placebo (3.9% vs. 8.8%). That being said, early reports suggest pill users may experience slightly higher rates of gastrointestinal discomfort during the ramp-up phase, possibly because oral delivery exposes the GI tract more directly to the medication. Research is ongoing to better understand how side effects differ, if at all, between the two administration types.
Most side effects are temporary and improve as your body adjusts. Starting at a low dose and increasing gradually helps minimize discomfort.
Wegovy isn’t right for everyone. Do not take if you have a family history of medullary thyroid carcinoma or MEN 2. Tell your provider about your full medical history before starting treatment.
Learn more: Overview of potential GLP-1 side effects
Convenience and adherence
Lifestyle and personal preference should be taken into account before choosing the pill or injection. Here are the main differences on adherence:
Wegovy pill:
- Administration type: Oral tablet
- Dosing frequency: Once daily
- Special instructions: Must be taken on an empty stomach with no more than 4 oz. of water. Wait 30 minutes to eat, drink, or take other medications.
- Needle required? No
- Best for: Needle-averse patients or those who don’t mind taking a pill every day
Wegovy injection
- Administration type: Subcutaneous (under the skin) self-injection
- Dosing frequency: Once weekly
- Special instructions: Rotate injection sites and keep injection pens refrigerated
- Needle required? Yes
- Best for: Those who prefer weekly dosing or more flexibility on timing of dose
Adherence is strongly linked to better outcomes, so the format you’ll actually stick with consistently will likely serve you best. For example, some prefer injections because they don’t want to take a pill on an empty stomach every day. Others prefer the pills so they don’t have to keep injection pens cold while traveling.
Always consult with a licensed provider to determine which medication type is best for you.
How Shed helps with Wegovy access
It would be nice if starting Wegovy for weight management was as simple as choosing between pills or injections, but, like most things related to healthcare, it’s more complicated than that. Cost, insurance coverage, medical history, response to medication, and personal preference all must be taken into account as well.
Shed simplifies what can be an overwhelming process by connecting you with a licensed provider who evaluates your medical history and health goals. If you qualify for treatment, they will create a personalized treatment plan. Medication is then shipped straight to your door, with ongoing care available to help you as you progress through treatment.
Visit tryshed.com today to learn more about how to access Wegovy through a Shed Membership and to see if you qualify.
Frequently asked questions
Is the Wegovy pill FDA approved?
Yes. The FDA approved the Wegovy pill (oral semaglutide 25 mg) in late December 2025 and launched in the U.S. in January 2026. It was the first oral GLP-1 medication approved for weight management.
What are the main differences between the Wegovy pill and injection?
Both contain semaglutide and work by mimicking the GLP-1 hormone to help reduce appetite and slow digestion. Key differences include how often the medication is taken (daily for pill, weekly for injectable), how it is taken (orally for pill, subcutaneously for injection), and when you take it (on an empty stomach for pill, any time for injection). Visit Wegovy’s website to learn more about dosing for the pill and injections.
How do I decide between the Wegovy pill and injection?
There’s no single right answer; it’s a personal decision best made with a licensed provider. Your daily routine, aversion to needles (if applicable), medical history, health goals, and side effects management should all be considered.
Can you switch from Wegovy injection to the pill?
Switching from Wegovy injections to the pill is possible, but it should always be done with guidance from your provider, never on your own. Because the two formulations have different dosing schedules and different dose strengths, your provider will determine the right starting dose for the pill based on where you’re at in your current treatment.
Does the Wegovy pill need to be refrigerated?
No, the Wegovy pill does not require refrigeration. The pill should be stored at room temperature in a cool, dry place away from direct sunlight and heat.
This content is for informational purposes only and is not medical advice. Consult a licensed healthcare provider before starting or changing any medication.
*In OASIS 4 clinical trials of the oral Wegovy® (semaglutide) pill, participants taking the medication with diet and exercise achieved average weight loss of about 14%–17% over ~64 weeks compared with ~2% with placebo. Some participants achieved ≥20% weight loss when treatment was continued. Results are not guaranteed and vary by individual and treatment adherence.
IMPORTANT SAFETY INFORMATION: Wegovy® may cause thyroid C-cell tumors, including thyroid cancer. Do not use Wegovy® if you or any of your family members have ever had medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). See full Prescribing Information including Boxed Warning at wegovy.com."
Wegovy® (semaglutide) is FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Results vary by individual and are not guaranteed. Weight loss depends on factors such as diet, exercise, adherence, medical history, and individual response.
Providers may evaluate patients and prescribe Wegovy® when clinically appropriate. Prescriptions are based on a medical evaluation and are at the provider’s discretion.
Shed is not a pharmacy and does not dispense medications. Prescriptions are fulfilled and shipped by a third-party pharmacy. Medications carry risks and side effects. Patients should review the full prescribing information and discuss risks with their provider.
Wegovy® is a registered trademark of Novo Nordisk. Shed is not affiliated with or endorsed by Novo Nordisk.
